Tanaka, Hiroyuki
Tanabe Pharma Corporation (Japan)
2 papers on CoChatORCID 0000-0002-4630-702X
Most cited papers
- Verified
Factors affecting canagliflozin-induced transient urine volume increase in patients with type 2 diabetes mellitus
Tanaka, H., Takano, K., Iijima, H., Kubo, H., Maruyama, N., Hashimoto, T., Arakawa, K., Togo, M., Inagaki, N., & Kaku, K. (2017) · Advances in Therapy
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 140
- Verified
Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
Hagiwara, N., Kawada-Watanabe, E., Koyanagi, R., Arashi, H., Yamaguchi, J., Nakao, K., Tobaru, T., Tanaka, H., Oka, T., Endoh, Y., et al. (2017) · European Heart Journal
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 136
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free